Who owns Immunomedics?

Key details on Immunomedics (Ticker: IMMU)

Who owns Immunomedics?

Is IMMU a good stock to own? Find out who bought Immunomedics, who sold Immunomedics (IMMU) stock, and who holds a large position in Immunomedics.

Fund Name Number of Shares Share Valuation As Of
FMR 13.81M $51.36M Sept. 30, 2014
Vanguard 3.48M $16.68M Dec. 31, 2014
BlackRock Fund Advisors 3.43M $16.46M Dec. 31, 2014
Deerfield Management Company 3.31M $15.87M Dec. 31, 2014
BlackRock Institutional Trust Company, N.A. 2.96M $14.22M Dec. 31, 2014
WCM Investment Management 1.91M $9.16M Dec. 31, 2014
S.A.C. Capital Advisors 1.40M $6.43M Dec. 31, 2013
Sigma Capital Management 1.38M $8.51M Sept. 30, 2013
SUSQUEHANNA INTERNATIONAL 1.33M $4.94M Sept. 30, 2014
STATE STREET CORPORATION 1.28M $6.14M Dec. 31, 2014
RA Capital Management 1000000 $3.65M June 30, 2014
NORTHERN TRUST 960579 $4.61M Dec. 31, 2014
Pine River Capital Management 875000 $2.11M March 31, 2013
Technical Financial Services 782459 $3.76M Dec. 31, 2014
Perceptive Advisors 737505 $4.57M Sept. 30, 2013
PanAgora Asset Management 560460 $2.69M Dec. 31, 2014
SPHERA FUNDS MANAGEMENT 534050 $1.99M Sept. 30, 2014
Geode Capital Management 527336 $2.53M Dec. 31, 2014
GOLDMAN SACHS 469316 $2.16M Dec. 31, 2013
Bailard 465000 $2.53M June 30, 2013
TIAA-CREF Investment Management 368573 $1.77M Dec. 31, 2014
DIMENSIONAL FUND ADVISORS 366488 $1.69M Dec. 31, 2013
Wellington Management Company 315608 $1.11M Sept. 30, 2012
Heather K. Mellem, Esq. 312229 $911708 Dec. 31, 2012
GSA Capital Partners 270490 $1.47M June 30, 2013

Who sold Immunomedics?

Fund Name Date Sold Number of Shares Sold Share Valuation
UBS AG Dec. 31, 2013 375350 $1.73M